$3.9 million financing completed by Consano Medical


consano medicalA $3.9 million unregistered equity financing by Consano Medical successfully drew to a close. The brokered investment round was placed among nine investors. The subscription started a little over a week ago. The private placement’s expected net proceeds amounts to $3.63 million which excludes $273,000 paid in brokerage fees. No offering was previously initiated by the company under a registration exemption with the SEC.

Consano Medical designs and markets minimally-invasive intelligent monitoring devices. The company’s first product, the Canary Catheter monitoring device, detects subtle changes in several physiological parameters: core body temperature, respiratory rate, heart rate, intra-abdominal pressure, and relative cardiac output. Tracking these changes may allow for earlier diagnosis and optimal treatment according to the company.

Daniel Burnett (CEO) leads the San Francisco CA based company which was registered in 2012. Consano Medical elected to keep its revenues undisclosed.

Offering recap
Status: Completed
Company: Consano Medical
Industry: Biotechnology
Amount offered: $3.9 million
Amount placed: $3.9 million
First sale: 05-13-2014
Data as of: 05-23-2014

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s